Severe irreversible proximal renal tubular acidosis and azotaemia secondary to cidofovir [4]

Nephron

Volumn 86, Issue 3, 2000, Pages 348-349

  Kay, Troy D ^a   Hogan, Patrick G ^a   Mcleod, Susan E ^a   Johnson, David W ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CALCIUM; CIDOFOVIR; CLARITHROMYCIN; COTRIMOXAZOLE; CREATININE; DRUG METABOLITE; INFUSION FLUID; MAGNESIUM; POTASSIUM; PROBENECID; RIFABUTIN; SODIUM CHLORIDE;

ADULT; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DOSE RESPONSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TUBULE ACIDOSIS; LETTER; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; RETINITIS; UREMIA;

ACIDOSIS, RENAL TUBULAR; ADULT; ANTI-HIV AGENTS; CYTOSINE; HIV INFECTIONS; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; UREMIA;

EID: 0033667758     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Anti-viral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines
2. (S)-1-(2-hydroxy-2-phosphonylmethoxy-propyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication
3. Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
4. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS
5. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): Results of a phase I/II study of a novel antiviral nucleotide analogue